Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures

OBJECTIVE: To evaluate the safety and tolerability of adjunctive eslicarbazepine acetate (ESL) in pediatric patients (aged 4-17 years) with refractory focal seizures. METHODS: Pooled safety data from patients aged 4-17 years in Study 208 (NCT01527513) and Study 305 (NCT00988156) were analyzed. Both...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Child Neurol
Autors principals: Mintz, Mark, Pina-Garza, Jesus E., Wolf, Steven M., McGoldrick, Patricia E., Józwiak, Sergiusz, Grinnell, Todd, Cantu, David, Costa, Raquel, Moreira, Joana, Li, Yan, Blum, David
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7005936/
https://ncbi.nlm.nih.gov/pubmed/31878820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0883073819890997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars